336 related articles for article (PubMed ID: 26751340)
1. Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules.
Cha MJ; Lee KS; Kim HS; Lee SW; Jeong CJ; Kim EY; Lee HY
Expert Rev Respir Med; 2016; 10(3):261-78. PubMed ID: 26751340
[TBL] [Abstract][Full Text] [Related]
2. Update in the evaluation of the solitary pulmonary nodule.
Truong MT; Ko JP; Rossi SE; Rossi I; Viswanathan C; Bruzzi JF; Marom EM; Erasmus JJ
Radiographics; 2014 Oct; 34(6):1658-79. PubMed ID: 25310422
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Patient With a Pulmonary Nodule: A Review.
Mazzone PJ; Lam L
JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
[TBL] [Abstract][Full Text] [Related]
4. Can spectral computed tomography imaging improve the differentiation between malignant and benign pulmonary lesions manifesting as solitary pure ground glass, mixed ground glass, and solid nodules?
Chen ML; Li XT; Wei YY; Qi LP; Sun YS
Thorac Cancer; 2019 Feb; 10(2):234-242. PubMed ID: 30582292
[TBL] [Abstract][Full Text] [Related]
5. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT.
Yi CA; Lee KS; Kim BT; Choi JY; Kwon OJ; Kim H; Shim YM; Chung MJ
J Nucl Med; 2006 Mar; 47(3):443-50. PubMed ID: 16513614
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives.
Sayyouh M; Vummidi DR; Kazerooni EA
Expert Opin Med Diagn; 2013 Nov; 7(6):629-44. PubMed ID: 24175679
[TBL] [Abstract][Full Text] [Related]
7. Solitary pulmonary nodule: detection and management.
Diederich S; Das M
Cancer Imaging; 2006 Oct; 6(Spec No A):S42-6. PubMed ID: 17114077
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
9. Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT.
Jeong YJ; Lee KS; Jeong SY; Chung MJ; Shim SS; Kim H; Kwon OJ; Kim S
Radiology; 2005 Nov; 237(2):675-83. PubMed ID: 16244276
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
Divisi D; Barone M; Zaccagna G; Crisci R
Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
[TBL] [Abstract][Full Text] [Related]
12. Solid or partly solid solitary pulmonary nodules: their characterization using contrast wash-in and morphologic features at helical CT.
Lee KS; Yi CA; Jeong SY; Jeong YJ; Kim S; Chung MJ; Kim HY; Kim YK; Lee KH
Chest; 2007 May; 131(5):1516-25. PubMed ID: 17494800
[TBL] [Abstract][Full Text] [Related]
13. Management of incidental pulmonary nodules: current strategies and future perspectives.
Kim TJ; Kim CH; Lee HY; Chung MJ; Shin SH; Lee KJ; Lee KS
Expert Rev Respir Med; 2020 Feb; 14(2):173-194. PubMed ID: 31762330
[No Abstract] [Full Text] [Related]
14. Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule.
Brawley OW; Flenaugh EL
Oncology (Williston Park); 2014 May; 28(5):441-6. PubMed ID: 25004661
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.
Dalli A; Selimoglu Sen H; Coskunsel M; Komek H; Abakay O; Sergi C; Cetin Tanrikulu A
J BUON; 2013; 18(4):935-41. PubMed ID: 24344020
[TBL] [Abstract][Full Text] [Related]
16. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
Lin KH; Lee RC; Liu RS; Chang CY
Nucl Med Commun; 2016 Apr; 37(4):356-62. PubMed ID: 26796032
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography quantitative analysis of components: a new method monitoring the growth of pulmonary nodule.
Linning E; Wu S; Wang K; Meng H; Sun D; Wu Z
Acta Radiol; 2013 Oct; 54(8):904-8. PubMed ID: 23761548
[TBL] [Abstract][Full Text] [Related]
19. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
Wahidi MM; Govert JA; Goudar RK; Gould MK; McCrory DC;
Chest; 2007 Sep; 132(3 Suppl):94S-107S. PubMed ID: 17873163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
